This evidence supports a model in which phosphorylation of PRMT5 may act as a pivotal step in enhancing the NF-κB response observed with PRMT5 overexpression which involves upregulation of the transcription of cancer-associated NF-κB target genes. Here, NFKB1 is linked to cancer.